FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103153013> ?p ?o ?g. }

• W2103153013 endingPage "732" @default.
• W2103153013 startingPage "724" @default.
• W2103153013 abstract "Plasma human immunodeficiency virus type 1 (HIV-1) RNA suppression <50 copies/mL is regarded as the optimal outcome of highly active antiretroviral therapy (HAART). Current viral load (VL) assays show increased sensitivity, but the significance of RNA detection <50 copies/mL is unclear.This study investigated the virologic outcomes of 1247 patients with VL <50 copies/mL at an arbitrary time point during HAART (= T0), according to whether the actual, unreported (T0)VL was 40-49 copies/mL, RNA detected <40 copies/mL (RNA(+)), or RNA not detected (RNA(-)), as measured by the Abbott Real Time assay. Predictors of rebound >50 and >400 copies/mL over 12 months following T0 were analyzed with Cox proportional hazards models incorporating the (T0)VL and demographic and clinical data.Rebound rates >50 copies/mL were 34.2% for (T0)VL 40-49 copies/mL, 11.3% for RNA(+), and 4.0% for RNA(-); rebound rates >400 copies/mL were 13.0%, 3.8%, and 1.2%, respectively. The adjusted hazard ratios for rebound >50 copies/mL were 4.67 (95% confidence interval, 2.91-7.47; P < .0001) and 1.97 (1.25-3.11; P < .0001) with (T0)VL 40-49 copies/mL and RNA(+), respectively, relative to RNA(-), and 6.91 (2.90-16.47; P < .0001) and 2.88 (1.24-6.69; P < .0001), respectively, for rebound >400 copies/mL. The association was independent of adherence levels.In treated patients monitored by RealTime, a VL of 40-49 copies/mL and, to a lesser extent, RNA detection <40 copies/mL predict rebound >50 and >400 copies/mL independently of other recognized determinants. The goal of HAART may need to be revised to a lower cutoff than 50 copies/mL." @default.
• W2103153013 created "2016-06-24" @default.
• W2103153013 creator A5004174170 @default.
• W2103153013 creator A5007447777 @default.
• W2103153013 creator A5008173217 @default.
• W2103153013 creator A5016768242 @default.
• W2103153013 creator A5036495713 @default.
• W2103153013 creator A5044331246 @default.
• W2103153013 creator A5054324011 @default.
• W2103153013 creator A5066429649 @default.
• W2103153013 date "2012-01-11" @default.
• W2103153013 modified "2023-10-12" @default.
• W2103153013 title "Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy" @default.
• W2103153013 cites W154148415 @default.
• W2103153013 cites W1984902481 @default.
• W2103153013 cites W1990698362 @default.
• W2103153013 cites W1991479571 @default.
• W2103153013 cites W2006776347 @default.
• W2103153013 cites W2013711784 @default.
• W2103153013 cites W2016865365 @default.
• W2103153013 cites W2054908871 @default.
• W2103153013 cites W2056833651 @default.
• W2103153013 cites W2082271099 @default.
• W2103153013 cites W2088056388 @default.
• W2103153013 cites W2104846025 @default.
• W2103153013 cites W2108967738 @default.
• W2103153013 cites W2109010689 @default.
• W2103153013 cites W2117261241 @default.
• W2103153013 cites W2119366692 @default.
• W2103153013 cites W2119974226 @default.
• W2103153013 cites W2121894695 @default.
• W2103153013 cites W2126547956 @default.
• W2103153013 cites W2131026328 @default.
• W2103153013 cites W2132826589 @default.
• W2103153013 cites W2139552123 @default.
• W2103153013 cites W2145331802 @default.
• W2103153013 cites W2145449008 @default.
• W2103153013 cites W2153661433 @default.
• W2103153013 cites W2164273972 @default.
• W2103153013 cites W2172124176 @default.
• W2103153013 cites W4240153861 @default.
• W2103153013 doi "https://doi.org/10.1093/cid/cir936" @default.
• W2103153013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22238167" @default.
• W2103153013 hasPublicationYear "2012" @default.
• W2103153013 type Work @default.
• W2103153013 sameAs 2103153013 @default.
• W2103153013 citedByCount "140" @default.
• W2103153013 countsByYear W21031530132012 @default.
• W2103153013 countsByYear W21031530132013 @default.
• W2103153013 countsByYear W21031530132014 @default.
• W2103153013 countsByYear W21031530132015 @default.
• W2103153013 countsByYear W21031530132016 @default.
• W2103153013 countsByYear W21031530132017 @default.
• W2103153013 countsByYear W21031530132018 @default.
• W2103153013 countsByYear W21031530132019 @default.
• W2103153013 countsByYear W21031530132020 @default.
• W2103153013 countsByYear W21031530132021 @default.
• W2103153013 countsByYear W21031530132022 @default.
• W2103153013 countsByYear W21031530132023 @default.
• W2103153013 crossrefType "journal-article" @default.
• W2103153013 hasAuthorship W2103153013A5004174170 @default.
• W2103153013 hasAuthorship W2103153013A5007447777 @default.
• W2103153013 hasAuthorship W2103153013A5008173217 @default.
• W2103153013 hasAuthorship W2103153013A5016768242 @default.
• W2103153013 hasAuthorship W2103153013A5036495713 @default.
• W2103153013 hasAuthorship W2103153013A5044331246 @default.
• W2103153013 hasAuthorship W2103153013A5054324011 @default.
• W2103153013 hasAuthorship W2103153013A5066429649 @default.
• W2103153013 hasBestOaLocation W21031530131 @default.
• W2103153013 hasConcept C104317684 @default.
• W2103153013 hasConcept C126322002 @default.
• W2103153013 hasConcept C142462285 @default.
• W2103153013 hasConcept C159047783 @default.
• W2103153013 hasConcept C207103383 @default.
• W2103153013 hasConcept C2993143319 @default.
• W2103153013 hasConcept C3013748606 @default.
• W2103153013 hasConcept C44249647 @default.
• W2103153013 hasConcept C50382708 @default.
• W2103153013 hasConcept C55493867 @default.
• W2103153013 hasConcept C67705224 @default.
• W2103153013 hasConcept C71924100 @default.
• W2103153013 hasConcept C86803240 @default.
• W2103153013 hasConcept C90924648 @default.
• W2103153013 hasConceptScore W2103153013C104317684 @default.
• W2103153013 hasConceptScore W2103153013C126322002 @default.
• W2103153013 hasConceptScore W2103153013C142462285 @default.
• W2103153013 hasConceptScore W2103153013C159047783 @default.
• W2103153013 hasConceptScore W2103153013C207103383 @default.
• W2103153013 hasConceptScore W2103153013C2993143319 @default.
• W2103153013 hasConceptScore W2103153013C3013748606 @default.
• W2103153013 hasConceptScore W2103153013C44249647 @default.
• W2103153013 hasConceptScore W2103153013C50382708 @default.
• W2103153013 hasConceptScore W2103153013C55493867 @default.
• W2103153013 hasConceptScore W2103153013C67705224 @default.
• W2103153013 hasConceptScore W2103153013C71924100 @default.
• W2103153013 hasConceptScore W2103153013C86803240 @default.
• W2103153013 hasConceptScore W2103153013C90924648 @default.
• W2103153013 hasIssue "5" @default.

• next